Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MOLECULIN BIOTECH, INC.

(MBRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Moleculin Biotech : Says Annamycin Chemotherapy Showed 'Preliminary Clinical Activity' in Interim Trial Data

10/18/2021 | 11:06am EST


ę MT Newswires 2021
All news about MOLECULIN BIOTECH, INC.
11/12Moleculin Biotech, Inc to Present at the Virtual Investor Roundtable Event
PR
11/12Moleculin Reports Third Quarter 2021 Financial Results and Provides Programs Update - F..
PU
11/11Moleculin Reports Third Quarter 2021 Financial Results and Provides Programs Update
PR
11/10MOLECULIN BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
11/10Moleculin Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
10/19MOLECULIN BIOTECH : Secures Approval to Conduct Phase 1a Trial of COVID-19 Treatment in UK
MT
10/19MOLECULIN BIOTECH : Receives Authorization from the Medicines and Healthcare Products Regu..
PU
10/19MOLECULIN BIOTECH : Receives Authorization from the Medicines and Healthcare Products Regu..
PR
10/19Moleculin Receives Authorization from the Medicines and Healthcare Products Regulatory ..
CI
10/18MOLECULIN BIOTECH : Says Annamycin Chemotherapy Showed 'Preliminary Clinical Activity' in ..
MT
More news
Analyst Recommendations on MOLECULIN BIOTECH, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -19,1 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,03x
Yield 2021 -
Capitalization 61,4 M 61,4 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 13
Free-Float 97,9%
Chart MOLECULIN BIOTECH, INC.
Duration : Period :
Moleculin Biotech, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MOLECULIN BIOTECH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 2,15 $
Average target price 19,00 $
Spread / Average Target 784%
EPS Revisions
Managers and Directors
Walter V. Klemp Chairman, President & Chief Executive Officer
Jonathan P. Foster Chief Financial Officer & Executive Vice President
Donald H. Picker Chief Science Officer
Robert Shepard Chief Medical Officer-Annamycin
Sandra Leta Silberman Chief Medical Officer-New Products
Sector and Competitors
1st jan.Capi. (M$)
MOLECULIN BIOTECH, INC.-55.05%61
JOHNSON & JOHNSON1.82%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049